The 2012 Cancer Diagnostics Market: New Product Development Opportunities, Market Penetration Strategies, Entry Barriers and Risks


March 28, 2012
15 Pages - SKU: VPG3815718
License type:
Table of Contents Related Reports
The report identifies major opportunities emerging in the cancer diagnostics market during the next ten years; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative business expansion strategies for suppliers.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.



More Oncology/Hematology reports by Venture Planning Group

2013 Analysis of the PT and APTT Point-of-Care Testing Market: US, Germany, Spain,-Physician Offices, Emergency Rooms, Operating Suites, ICIs/CUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers by Venture Planning Group
This new 366-page report from Venture Planning Group contains 39 tables, and provides a comprehensive analysis of the PT and APTT testing in POC locations, ...
Competing in the European Cancer Diagnostics Market: France, Germany, Italy, Spain, UK by Venture Planning Group
This new 820-page five-country report from Venture Planning Group identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five ...
Competing in the US Cancer Diagnostics Market by Venture Planning Group
HighlightsThis new 620-page study of the US cancer diagnostics market from Venture Planning Group provides:Major issues pertaining to the US laboratory practice, as well as ...
Competing in the Global Cancer Diagnostics Market by Venture Planning Group
This new Venture Planning Group comprehensive seven-countrystudy identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the nextfive years; examines trends ...
See all reports like this >>

 
Research assistance
We can help you find what you need. Call us or write us:
US: 800.298.5699
Int'l: +1.240.747.3093
Need help in your search?
 
Related Markets

Oncology/Hematology Reports
 
 

Share this report


Other tasks

 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!